Skip to main content
. 2021 Dec 30;10(14):34. doi: 10.1167/tvst.10.14.34

Table 1.

Participant and Study Eye Characteristics Overall and by Training and Test Data Subsets

Protocol O Overall Protocol O Train Data Protocol O Test Data CADME Data
No. of participants 107 75 32 37
Sex, n (%)
 Female 51 (48) 35 (47) 16 (50) 12 (32)
 Male 56 (52) 40 (53) 16 (50) 25 (68)
Race/ethnicity, n (%)
 Asian 3 (3) 2 (3) 1 (3) 1 (3)
 Black/African American 38 (36) 25 (33) 13 (41) 1 (3)
 Hispanic or Latino 3 (3) 2 (3) 1 (3) 0
 White 63 (59) 46 (61) 17 (53) 34 (92)
Age, years
 Mean (SD) 62.7 (10.3) 62.2 (9.7) 63.9 (11.7) 63.5 (9.7)
 Median (IQR) 63 (57 to 70) 63 (57 to 69) 68 (57 to 72) 62 (58 to 68)
Diabetes type, n (%)
 Type 1 8 (7) 6 (8) 2 (6) 6 (16)
 Type 2 99 (93) 69 (92) 30 (94) 31 (84)
Duration of diabetes, years
 Mean (SD) 16.7 (9.9) 17.1 (9.5) 15.6 (10.8) 13.1 (9.3)
 Median (IQR) 16 (10 to 22) 16 (10 to 22) 15 (8 to 22) 12 (5 to 18)
Insulin used, n (%)
 No 39 (36) 26 (35) 13 (41) 19 (51)
 Yes 68 (64) 49 (65) 19 (59) 18 (48)
Study eyes, n (%)
 Bilateral 80 (75) 56 (75) 24 (75) 0
 Unilateral 27 (25) 19 (25) 8 (25) 37 (100)
No. of eyes 187 131 56 37
Visual acuity, n (%)
 ≥20/40 124 (66) 88 (67) 36 (64) 0
 20/50–20/100 46 (25) 33 (25) 13 (23) 19 (51)
 ≤20/100 17 (9) 10 (8) 7 (13) 18 (48)
Lens status, n (%)
 PC IOL 75 (40) 47 (36) 28 (50) 0
 Phakic 112 (60) 84 (64) 28 (50) 37 (100)
Mean of CST test-retest on Spectralis, µm
 Mean (SD) 386 (111) 383 (99) 394 (135) NA
 Median (IQR) 361 (305 to 432) 365 (307 to 432) 349 (305 to 432) NA
 Range 229 to 875 229 to 740 251 to 875 NA
Mean of CST test–retest on Cirrus, µm
 Mean (SD) 365 (113) 362 (100) 372 (140) NA
 Median (IQR) 340 (283 to 406) 346 (290 to 406) 334 (283 to 398) NA
 Range 176 to 845 185 to 723 176 to 845 NA
No. of measurement pairs 374 262 112 150
Difference of CST on Spectralis - Cirrus, µm
 Mean (SD) 21 (30) 21 (27) 21 (36) 9 (8)
 Median (IQR) 17 (11 to 28) 17 (11 to 26) 18 (10 to 32) 8 (6 to13)
 Range −172 to 171 −84 to 170 −172 to 171 −40 to 26

NA, Not available. The CADME Study did not have test–retest data.